{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:22:09Z","timestamp":1765959729913,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jdiacomp.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T23:00:53Z","timestamp":1393714853000},"page":"553-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Lamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gafni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tyrwhitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/135581969800300410","article-title":"The distribution of health care costs and their statistical analysis for economic evaluation","volume":"3","author":"Briggs","year":"1998","journal-title":"Journal of Health Services Research & Policy"},{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians","volume":"19","author":"Carpender","year":"2000","journal-title":"Statistics in Medicine"},{"year":"1996","series-title":"Cost-effectiveness in health and medicine","author":"Gold","key":"10.1016\/j.jdiacomp.2014.02.012_bb0025"},{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0015","first-page":"95","article-title":"The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trial","volume":"28","author":"Lamy","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3111\/13696998.2011.627405","article-title":"The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: The ONTARGET study","volume":"14","author":"Lamy","year":"2011","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2007.09.009","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)","volume":"155","author":"The ORIGIN Trial Investigators.","year":"2008","journal-title":"American Heart Journal"},{"key":"10.1016\/j.jdiacomp.2014.02.012_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"The ORIGIN Trial Investigators.","year":"2012","journal-title":"The New England journal of medicine"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:07:12Z","timestamp":1761005232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872714000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1056872714000543"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.02.012","relation":{},"ISSN":["1056-8727"],"issn-type":[{"type":"print","value":"1056-8727"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}